NCT01879397 Pilot Study of Ultrasonic Determined Carotid Plaque Composition Status COMPLETED Phase N/A
NCT01873716 Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque Status COMPLETED Phase PHASE1
NCT01873339 Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01867736 BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries Status COMPLETED Phase NA
NCT01866761 Relationship Analysis Between Periodontal Disease and Atherosclerosis in Japanese Medical Cooperation Services Status COMPLETED Phase N/A
NCT01859793 Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy Status COMPLETED Phase PHASE4
NCT01852565 Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848). Status COMPLETED Phase PHASE1
NCT01834495 Efficacy of Balloon-Expandable Stent Versus Self-Expandable Stent for the Atherosclerotic ILIAC Arterial Disease Status COMPLETED Phase NA
NCT01833585 Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells Status COMPLETED Phase PHASE3
NCT01751074 To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01750827 A Study to Assess the Effect of SB 659032 on Platelet Function Status COMPLETED Phase PHASE1
NCT01747525 Near-Infrared Spectroscopy and Ultrasound Investigation of Coronary Artery Plaque Status WITHDRAWN Phase N/A
NCT01742000 Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women Status COMPLETED Phase PHASE3
NCT01741974 Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women Status COMPLETED Phase PHASE3
NCT01724749 Cardiovascular Molecular Calcification Assessed by 18F-NaF PET CT Status UNKNOWN Phase N/A
NCT01711723 A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment Status COMPLETED Phase PHASE1